{
  "id": "06ea3b01e2f968e0",
  "title": "FDA Approves Subcutaneous Amivantamab for EGFR+ NSCLC",
  "description": "20251218T014500Z",
  "content": "",
  "source": "onclive.com",
  "source_url": "https://www.onclive.com/view/fda-approves-subcutaneous-amivantamab-for-egfr-nsclc",
  "published_at": "20251218T014500Z",
  "fetched_at": "2025-12-19T00:23:08.544189+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.onclive.com/view/fda-approves-subcutaneous-amivantamab-for-egfr-nsclc",
    "url_mobile": "",
    "title": "FDA Approves Subcutaneous Amivantamab for EGFR+ NSCLC",
    "seendate": "20251218T014500Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/onclive/a96f95812b87a9220551db482aa0265d28720d59-1280x720.png",
    "domain": "onclive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}